149 related articles for article (PubMed ID: 36029138)
1. Identification of novel signal of clobazam-associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis.
Sharma A; Kumar A
Acta Neurol Scand; 2022 Nov; 146(5):623-627. PubMed ID: 36029138
[TBL] [Abstract][Full Text] [Related]
2. Vemurafenib Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Disproportionality Analysis in FAERS Database.
Neha R; Beulah E; Anusha B; Vasista S; Stephy C; Subeesh V
Curr Rev Clin Exp Pharmacol; 2021; 16(2):168-173. PubMed ID: 32598268
[TBL] [Abstract][Full Text] [Related]
3. Identification of Novel Signals Associated with US-FDA Approved Drugs (2013) Using Disproportionality Analysis.
Raghuvanshi S; Rahman MA; Posa MK; Kumar A
Curr Drug Saf; 2023 Nov; ():. PubMed ID: 37990902
[TBL] [Abstract][Full Text] [Related]
4. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
Kim HK; Kim DY; Bae EK; Kim DW
J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Analysis of Topiramate and Drug Reaction With Eosinophilia and Systemic Symptoms.
Thoms A; Muller P; Schaufelberger B; De La Torre E; Smugar SS
Cureus; 2023 Jan; 15(1):e33713. PubMed ID: 36643088
[TBL] [Abstract][Full Text] [Related]
6. Real-world safety of Levetiracetam: Mining and analysis of its adverse drug reactions based on FAERS database.
He Z; Liu C; Lin L; Feng G; Wu G
Seizure; 2024 Apr; 117():253-260. PubMed ID: 38537425
[TBL] [Abstract][Full Text] [Related]
7. Identification of Signal of Clindamycin Associated Renal Failure Acute: A Disproportionality Analysis.
Javed F; Kumar A
Curr Drug Saf; 2024; 19(1):123-128. PubMed ID: 36852785
[TBL] [Abstract][Full Text] [Related]
8. Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by phenytoin re-exposure: case report and systematic review.
Morán-Mariños C; Alva-Diaz C; De la Cruz Ramirez W; Quincho-Lopez A; Mori N; Pacheco-Mendoza J; Romero-Sánchez R
Acta Clin Belg; 2022 Feb; 77(1):177-185. PubMed ID: 32469684
[No Abstract] [Full Text] [Related]
9. Recrudescence of Severe Carbamazepine- Induced DRESS Syndrome after Initiation of Levetiracetam.
Jiang SW; Floyd L; Cardones AR; Selim MA; Shearer SM
Skinmed; 2023; 21(6):445-447. PubMed ID: 38051248
[TBL] [Abstract][Full Text] [Related]
10. Association of antiviral drugs and their possible mechanisms with DRESS syndrome using data mining algorithms.
Sharma A; Roy S; Sharma R; Kumar A
J Med Virol; 2023 Mar; 95(3):e28671. PubMed ID: 36916721
[TBL] [Abstract][Full Text] [Related]
11. A Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Clobazam.
Manyas H; Paketci C; Okur D; Bayram E; Hiz S; Yis U
Pediatr Emerg Care; 2020 Mar; 36(3):e175. PubMed ID: 30870346
[No Abstract] [Full Text] [Related]
12. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system.
Wu Z; Zhou P; He N; Zhai S
Front Cardiovasc Med; 2022; 9():966331. PubMed ID: 36352852
[TBL] [Abstract][Full Text] [Related]
14. Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review.
E L omairi N; Abourazzak S; Chaouki S; Atmani S; Hida M
Pan Afr Med J; 2014; 18():9. PubMed ID: 25360193
[TBL] [Abstract][Full Text] [Related]
15. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases.
de Filippis R; Kane JM; Kuzo N; Spina E; De Sarro G; de Leon J; De Fazio P; Schoretsanitis G
Eur Neuropsychopharmacol; 2022 Jul; 60():25-37. PubMed ID: 35635994
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database.
Agier MS; Boivin N; Maruani A; Giraudeau B; Gouraud A; Haramburu F; Jean Pastor MJ; Machet L; Jonville-Bera AP
Br J Dermatol; 2016 Nov; 175(5):1067-1069. PubMed ID: 27060861
[No Abstract] [Full Text] [Related]
17. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms.
Mehrholz D; Urban AE; Herstowska M; Nowicki R; Cubała W; Barańska-Rybak W
Psychiatr Pol; 2017 Dec; 51(6):1079-1093. PubMed ID: 29432504
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital.
Ramírez E; Medrano-Casique N; Tong HY; Bellón T; Cabañas R; Fiandor A; González-Ramos J; Herranz P; Trigo E; Muñoz M; Borobia AM; Carcas AJ; Frías J
Br J Clin Pharmacol; 2017 Feb; 83(2):400-415. PubMed ID: 27543764
[TBL] [Abstract][Full Text] [Related]
20. Incidence of drug-induced hypersensitivity syndrome associated with levetiracetam and clobazam is likely underreported.
Kichili NR; Hansen A; Kagithala D; Gonzalez AM; Wilkerson M
Ann Allergy Asthma Immunol; 2024 May; 132(5):652-653. PubMed ID: 38346472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
